The US has approved a new type of eye drop which they say could eliminate the need for reading glasses.
The FDA (Food and Drug Administration) recently approved the use of an eye drop designed to improve age-related near-vision, reports Express.co.uk.
Called Vuity, the drop is applied to each eye once a day and starts working within 15 minutes of application. The makers say each drop lasts for at least six hours.
As per the report, the drug is a formulation of a well-known compound known as pilocarpine.
The researchers behind Vuity designed it to allow for the eye drop to rapidly adjust to the pH of the tear film.
What the drop does is take advantage of the eye's ability to reduce pupil size, improve near-vision whilst maintaining distance vision.
The drop has been found to be most effective for those between the ages of 40 and 55.
Results have come from two randomised control trials on 750 subjects, the report said.
It was during these studies that Vuity was observed to start working within 15 minutes of application.
In a positive piece of news, the drops were found to result in no serious side effects. However, some patients experienced mild headaches and eye redness.
--IANS
vc/dpb
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve hit your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Quarterly Starter
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories Online
Over 30 behind the paywall stories daily, handpicked by our editors for subscribers


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app